Pharmaceutical Industry News Archive
Get news by email or subscribe to our news feeds.
News Archive for February 2010
February 1, 2010
- UCB (BE) - UCB Accelerates Transition to Become Patient-Centric Global Biopharmaceutical Leader With Decision To Exit The Primary Care Market in the U.S.
- Dash For Diet Drug
- Pfizer Muddies the Waters of Red Wine's Fountain of Youth
- Cephalon Acquires Swiss Drugmaker Mepha AG
- Cephalon, Inc. Announces Agreement to Acquire Mepha AG
- The Indianapolis Star Daniel Lee Column: Peterson Still Mixes With Pols, but Now on Eli Lilly's Behalf
- Boston Scientific to Pay JNJ $1.73 Billion in Settlement
- FDA Announces Safety Risk Associated with HIV Drug
February 2, 2010
- Novo Nordisk Profits Largely Unchanged in Q4
- Reports: Glaxo to Cut Thousands of Jobs
- Abbott and Pierre Fabre SA Announce Collaboration to Research and Develop Novel Treatments for Cancer
- Novo Nordisk increased operating profit by 21% in 2009
- Antidepressant May Result in Improved Cognitive Function After Stroke
- First Treatment To Improve Survival In 20 Years Now Available For Patients With Osteosarcoma (Bone Cancer)
- Abbott, Pierre Fabre Ink Licensing Deal for Cancer Treatment
- GSK Could Cut Thousands More
- Onyx Names New Head Of R&D
- Evotec And Vifor Pharma Enter Into Two Year Cooperation Agreement
February 3, 2010
- Roche FY Net Profit Down 22 Percent on Genentech Costs
- Pfizer Reports Fourth-Quarter and Full-Year 2009 Results; Provides 2010 Financial Guidance and 2012 Financial Targets
- Podcast Series From Med Ad News Magazine Tackles Important Healthcare Communications Issues
- Labopharm Gets FDA Approval for Once-a-Day Oleptro
- Pfizer Posts Big Jump In 4Q Sales, Profit
- FDA Oks Dupuytren's Contracture Drug
- Glaxo CEO: Time To Diversify, Help Poor Countries
- Biomedical Jobs Appear to Be 'Recession Resilient'
- Genzyme Names Global Manufacturing President
February 4, 2010
- Drugmaker Employee in NY Charged with Trade Theft
- FDA Sends Letter to Eli Lilly Regarding Promotions for Adcirca
- FDA Sends Letter to Meda Regarding Promotions for Astelin
- FDA Sends Letter to Sanofi Aventis Regarding Promotion for BenzaClin
- FDA Sends Letter to Novalar Regarding Promotions for OraVerse
- GSK announces appointment of Philippe Fauchet as President of GSK Japan
- Poniard Pharmaceuticals Announces Management Changes and Reduction in Force
- GSK launches new specialist unit to research and develop medicines for rare diseases
- GlaxoSmithKline Q4 Profit Up 66 Pct
February 5, 2010
- Miss. Settles Zyprexa Suit For More Than $18 Million
- Seniors Aren't Getting Vital Vaccinations, Study Finds
- Alkermes Reports 3Q Loss, Smaller Than Expected
- Teva Pharma Settles Some Medicaid Drug Price Suits
- Glaxo Savings Plan May Hit Xenoport Partnership
- Biomarin To Buy LEAD For $97M, Gives 2010 Outlook
- Diabetes Killed J&J Heiress
- Mississippi AG: Zyprexa Settlement to Offset Budget Cut
February 8, 2010
- Even if You're Careful, Drugs Can End up in Water
- Bristol-Myers Squibb to Stop All Non-Mandated Salary Raises in 2010 to Cut Costs
- FDA Warns of Brain Risks with Frequent Tysabri Use
- Bristol-Myers Squibb to Stop All Non-Mandated Salary Raises in 2010 to Cut Costs
- FDA Drug Safety Communication: Risk of Progressive Multifocal Leukoencephalopathy (PML) with the use of Tysabri (natalizumab)
- Novavax Terminates Negotiations with ROVI Pharmaceuticals for Influenza Vaccine Collaboration
- Pfizer To Sell Viagra In Israel Via Internet
- Getting Shingles Vaccine Easier
February 9, 2010
- The Internet Has More Influence Over Consumer Health Actions than Traditional DTC Channels
- Eli Lilly CEO's Total Pay Rose To $20.9M In 2009
- AstraZneca Gets OK for Expanded Crestor Use
- Biogen Idec Reports Full Year and Fourth Quarter 2009 Results
- Biogen 4Q Profit Grows 48 Percent On Tysabri Sales
- Pfizer Teams Up to Offer Online Health Management
- Glaxo Considering Job Cuts At UK Research Center
- Amgen Sees Positive Data In Bone Drug Study
February 10, 2010
- Irish Drugmaker Elan Slumps to Q4 Loss
- Sanofi-Aventis Q4 Profit up on Swine Flu Vaccines
- Elan Reports Fourth Quarter and Full-Year 2009 Financial Results
- Alexza and Biovail Form Collaboration to Develop and Commercialize AZ-004 (Staccato Loxapine) in North America
- Daiichi Sankyo to Launch Innovator Products in Mexico through Ranbaxy
- Pharmasset Reports Smaller Fiscal 1Q Loss
- NICE Updates Draft Guidance on Dasatinib and Nilotinib for Chronic Myeloid Leukemia
- Ricerca Announces Intent to Acquire MDS Pharma Services Business
February 11, 2010
- Boston Scientific Cuts Staff as Costs Persists
- RadPharm and Medifacts International Merge to Form Leading Independent Core Lab
February 12, 2010
- Drug Makers' Top Lobbyist Stepping Down
- Genzyme Updates Data on Gaucher Drug
- Abbott Gets European Clearance for Solvay Deal
- Roche and Artery Therapeutics launch new collaboration in cardiovascular disease
- Zymogenetics Posts 4Q Profit On Recothrom Revenue
- SLU Will Snap Up Ex-Pfizer Staff
- Alcon Profit Climbs 8 Percent In 4th Quarter
- Abbott Receives U.S. FDA Approval for Heat-Stable Norvir (ritonavir) Tablets
- Former Exec Sues Pfizer Over Lipitor Marketing
- Philippine Court Denies Pfizer Petition To Block Generic Drug Variant
- Alcon Independent Director Committee Says Company's Q4/FY 2009 Financial Results Underscore Gross Inadequacy of Novartis' Proposal to Minority Shareholders
- NABP Commends Google's VIPPS-Accreditation Requirement for Internet Pharmacy Advertisers
February 16, 2010
- Private Drug Tester Expands Stake In Big Pharma
- No Health Care Overhaul Will Bring More Problems
- Schering-Plough Purchase Hikes Merck Sales, Profit
- Teva Pharmaceutical Reports 4th-Quarter Profit
- United Therapeutics Closes Loss Gap In 4Q
- AstraZeneca and Rigel Pharmaceuticals Sign Worldwide License Agreement for Late-Stage Development Product -- Fostamatinib Disodium (R788) -- for the Treatment of Rheumatoid Arthritis (RA)
- Abbott Completes Acquisition of Solvay Pharmaceuticals
- Dainippon Sumitomo Pharma: Second Mid-term Business Plan
- Teva Pharmaceutical Settles Lawsuit with Novartis
- FDA Asks Amgen, J&J To Discuss Anemia Drug Risks
- Teva Pharmaceutical Settles Lawsuit With Novartis
- Vanda 4Q Loss Widens On Expenses
- Amgen and Centocor Ortho Biotech Products Finalize ESA Risk Evaluation and Mitigation Strategy (REMS) With FDA
- Abbott Closes $6.2 Billion Solvay Unit Buyout
February 17, 2010
- FDA Announces New Safety Plan for Agents Used to Treat Chemotherapy-Related Anemia
- Covidien Says FDA Adds a Week to Pain Drug Review
- Jury Awards $25 Million in Damages to US Man Over Side Effects of Accutane
- Covidien Says FDA Adds a Week to Pain Drug Review
- NY Court Overturns Adoption by J&J Heiress
- Arkansas Announces $18.5 Million Settlement with Eli Lilly
- Lilly's Effient Is a Slow Starter
- Auxilium Pharma 4Q Loss Narrows On Testim Sales
- Doctors Weigh In On Antidepressants
- RiskMetrics Group Questions Adequacy and Legality of Novartis' Merger Proposal to Alcon's Minority Shareholders
February 18, 2010
- WHO: Add Swine Flu to Regular Flu Vaccine
- FDA Eyes Overhaul for Medical Device Approvals
- Sanofi-Aventis Enters French Research Partnership
- Taro Announces Planned Discontinuation of Manufacturing Operations at Its Irish Facility
- Physicians Say No to DTC Advertising for Medications that Treat Mental Disorders
- Dynavax and GlaxoSmithKline Select Clinical Candidate in the Endosomal TLR Inhibitor Program
- Regeneron, Bayer Eye Drug Meet Study Goal
- Exjade (deferasirox): Boxed Warning - Changes to Prescribing Information re: risk of renal impairment/failure, hepatic impairment/failure or gastrointestinal hemorrhage
- Oncothyreon announces sale of Oncothyreon Canada
February 19, 2010
- Excellent Results in a Transformational Year for Shire; Core Product Sales up 25%
- GSK Statement on FDA's Proposed Label Revisions for Some Asthma Medicines
- FDA Cancer Drug Approval Rate Highlighted in JNCI
- FDA Issues Warning On 4 Widely-Used Asthma Drugs
- Roche's Rituxan Gets US OK For Another Cancer
- J&J Changing Bonus Plan To Reward Performance More
- Sepracor Announces New Management Changes and Plans for Merger with Dainippon Sumitomo Pharma America
- J&J Partner Says EU Rejecting Skin Infection Drug
February 22, 2010
- Senate Report: Avandia Maker Knew of Cardiac Risks
- FDA Announces Boxed Warning for Exjade
- Baucus, Grassley Release Finance Committee Report on Diabetes Drug Avandia, Express Concern About FDA?s Role in Protecting Patients in Ongoing Avandia Study
- FDA Informs Eisai Medical Research on 'Misleading' Aricept TV Ads
- Regulatory Science Update: FDA and International Serious Adverse Events Consortium Complete Third Data Release
- Retin-A Researcher Albert Kligman Dies
- Drug Case Will Cost Cardinal $1 Million
- Genzyme Receives Notice of Icahn Partners' Nomination of Directors
- Genzyme Faces Proxy Challenge From Icahn
- FDA to Complete Review Of Amgen's Prolia In July
February 23, 2010
- Roche, Genentech Report Avastin Study Failure
- Merck Makes Fourth Quarter Net Profit of $78 Million
- US Drug Company Agrees to Pay $3.5 Settlement
- US Doctor Pleads Guilty to Research Fraud
- FY2009: Merck KGaA Revenues Increase by 2.1% to ? 7.7 Billion
- Gardasil approved by Health Canada for males to prevent genital warts
- Avandia (rosiglitazone): FDA reviewing a large, long-term clinical study on possible risks for cardiovascular outcomes with use of rosiglitazone
- Avandia Fallout Could Hit Triangle
- Drug Company Eon Labs Pays $3.5 Million to Settle False Claims Act Allegations Concerning Reimbursement Claims for Less Than Effective Drug
- FDA Reviews Avandia Safety Data
- Viamet Teams Up With Novartis
- Pharmaceutical Industry Support Not Desirable but Frequently Accepted by Residency Program Directors
- Lilly, Merck, And Pfizer Join Forces To Accelerate Research And Improve Treatment Of Lung And Gastric Cancers In Asia
- Icahn Nominates 4 to Genzyme Slate
February 24, 2010
- FDA Drug Safety Communication: Ongoing safety review of Invirase (saquinavir) and possible association with abnormal heart rhythms
- Invirase (saquinavir): Ongoing safety review of clinical trial data-Possible association with abnormal heart rhythms when used in combination with Norvir (ritonavir)
- Millipore Corporation Confirms It is Evaluating Strategic Alternatives
- FDA Places Shire Drug Application On Fast Track
- OSI 4Q Profit Drops, But Tarceva Sales Rise
- Arena Weight Loss Drug Under FDA Review
- FDA Warns Of Heart Risk With HIV Drug Combination
- Shire Provides Update on Biologics License Application (BLA) Filing for Replagal (agalsidase alfa) With the U.S. Food and Drug Administration (FDA)
- Ala. Woman Wins $9.45 Million In Wyeth-Hormone Suit
- H. Lundbeck A/S (DK) - Lundbeck Expands the Agreement with Teva to Include Marketing of Azilect in Selected Asian Countries
- Pfizer Says FDA Oks Updated Infection Vaccine
- Canon Communications Will Launch Medical Electronics Design Events in the U.S., Japan, and China, in 2010
February 25, 2010
- Panel Recommends Annual Flu Vaccinations for All
- Pfizer Says FDA OKs Updated Infection Vaccine
- King Pharmaceuticals Reports Full Year and Fourth-Quarter 2009 Financial Results
February 26, 2010
- Lilly Settlement to Fund MT Mental Health Services
- Pfizer's Ringo to Retire from Senior VP Post
- KV to Close Ethex Unit and Plead Guilty to Charges
- Regulus and Glaxo Will Work on Hepatitis C Drugs
- Philippines to Lower Prices on More Medicines
- IMS Health Announces Completion of Acquisition by Affiliates of TPG and the CPP Investment Board
- ConjuChem Files for Restructuring
